



The aim of this essay is to analyse the financial statements of the company Medcom  
Tech, S.A. that devotes itself to the commercialization of technologically advanced 
products in the area of health. I’ll try to analyse if the company generates positive 
benefits and appellants in the time; if these are enough to attend its commitment of 
payment; if the financing structure used is adapted to the typology of investment 
realized; if the management of the assets allows profitability of the economic 
resources, which in turn allows a suitable remuneration of the invested capital. Also, I 
will analyse its point of balance (break-even point), to analyse its operative risk against 
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1. INTRODUCTION, AIMS AND STRUCTURE OF THE ESSAY  
 
The topic of the essay is very interesting because the analysis of the financial 
statements is a way of synthesizing the most valuable information of the company in 
order to be able to interpret it. They offer a more detailed and visual view of the 
economic and financial situation.  
 
Having said that, it can be said that a correct analysis and interpretation of the financial 
statements can make taking decisions easier by reducing the level of uncertainty.  
 
On the one hand, the balance sheet of situation shows the patrimonial situation of the 
company during the period analysed through the assets, liabilities and net. On the 
other hand, the profit and loss report shows accurately the income and expenses that 
the company generates during its activity. 
 
1.1  THE AIMS OF THE ESSAY  
 
The main aim is to analyse the financial results of Medcom Tech and make a 
conclusion about its situation. Therefore, the aim of this essay is to conduct an analysis 
as complete as possible of Medcom Tech, for which it turns out essential to consider 
the annual accounts, as well as the report of management and the auditing report.  
 
1.2  STRUCTURE OF THE ESSAY  
 
I began the essay with a research in the report of the annual accounts, information of 
the company´s website http://www.medcomtech.es/es/, as well as information gathered 
on the internet, not only in websites but also in online magazines articles. With the aim 
of getting myself familiar with the company, Medcom Tech.  
 
The first section of the essay explains the following question: What can we learn from 
the accounting statement? The essay starts with an accounting analysis which tries to 
show the liquidity of the assets, the profitability of the company, etc.   
 
The methodology that I have used to analyse Medcom Tech primarily consists of taking 
into account the qualitative aspects, such as the strategic ones, to do a more complete 




 Qualitative analysis:  
 
As a previous step before the analysis of the financial states, it is useful to do a 
qualitative analysis, where the strategy and activity of the company is described. The 
purpose of the qualitative analysis is to understand how Medcom Tech operates and 
the current situation of the company and where it wants to go.  
 
 Strategic analysis:  
 
In particular, the strategic analysis tries to diagnose the competitive position of the 
company, Medcom Tech, keeping in mind aspects such as its products, and the sector 
in which it operates. Once the strategic analysis is done, it is possible to begin the 
analysis of the financial statement. 
 
 Analysis of the annual accounts:   
 
The second part of the essay describes the analysis of the annual accounts which will 
be explained following the next parts:  
 Patrimonial and financial analysis: This analysis tries to study and make an 
assessment of the capitalization, the debt and the liquidity. 
  
 Asset management analysis: This analysis works with the analysis of the 
rotation (turnover), the period (days) and the rolling fund (working capital).  
 
 Economic analysis: This analysis is used to show the evolution of the results 
 
 Analysis of profitability and self-financing: This analysis makes it possible to 
assess the factors that affect profitability (margin, rotation, leverage) and the 






- Patrimonial analysis:  
The patrimonial analysis studies the level of Medcom Tech´s debt and his financial 
balance. This reflects the guarantee that offers to his suppliers and lenders. It also lets 
you know the degree of liquidity to pay the short-term liabilities. All this can be figured 
out with the analysis of the balance sheet.  
The patrimonial report (equity analysis) is the analysis of the balance sheet structure. It 
studies the composition of the elements that integrate the balance sheet, its weight 
inside the set of assets, liabilities and net income. The way used to analyse the assets 
and liabilities are the breakdown analysis, whereas for the study of the net income 
different types of ratios are used.  
The ratios that have been included in the essay are the most popular in the financial 
literature. The aim is to focus on an economic financial analysis that could show the 
solvency and profitability.  
Within solvency ratios, I have worked with ratios in order to explain the liquidity, the 
indebtedness, the basic structure and the degree of debt coverage. Furthermore, to 
study the profitability, the economic and financial profitability have been analysed 
thoroughly.  
- Financial analysis:  
In order to study the financial structure of any company, in this case Medcom Tech, it is 
necessary to study the profitability of investments and self resources, as well as the 
cost of the financial resources. In my essay, I used the balance sheet and the profit and 
loss report to carry out the financial analysis.  
- Economic research:  
Through the economic research it is possible to see which elements provide the 
company the desired profitability, and shows the development and the profit margin. 
This research takes as a background report the profit and loss account.  
Finally, after introducing in a global way what the main aim of the essay is, the next 
step is the part where it is necessary to ask: How to do a countable analysis?  
The accounting analysis carried out during the essay offers two faces. On the one 
hand, the static, which shows the analysis at a particular time; on the other hand, the 
dynamics, which presents the evolution of the company.  
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In order to do the accounting analysis, I started with the analysis of the information 
provided by the consolidated financial statements, with their evolution and comparison. 
Then I have used a few ratios, as this is the most famous method and the most 
accepted tool to analyse the accounting information for its relative simplicity.  
Nevertheless, I have used few ratios in order to make easier to understand, what I want 
to say is that I have chosen to use the main ratios, as the objective is to provide a 
global vision of the company. This also means that in order to interpret them correctly 
you can not only focus on the result, but also you have to use additional information, 
such as where the data used come from. Having information of several years is 
another aspect that turns out to be important in order to be able to analyse the 
company, and to evaluate the progress that follows the analysed aspects.  
After the strategic and financial analysis, the last part of this essay that introduces the 
first assessment of Medcom Tech global situation can be done. 
 
 
Once introduced which is the structure and aims of the essay I give way to the analysis 






2. OUTLINE OF THE COMPANY´S ACTIVITY  
 
MEDCOM TECH S.A GENERAL DESCRIPTION  
 
2.1 MEDCOM TECH´S ACTIVITY  
 
Medcom Tech S.A is a company created in 2001 in Barcelona, Spain. Its corporate 
purpose is the commercialization of technologically advanced products in orthopaedic 
surgery, traumatology, neurosurgery and anaesthesia.  
The enterprise is available in a market with a great growth potential. It can be said that 
it is a company that operates in the area of health with the aim of identifying innovative 
products and to distribute them across its sales network in different countries, such as 
Spain, Portugal, Italy and Dominican Republic.  
Medcom Tech turns out to be a very interesting company, because besides the fact 
that is a solid company specialised in medical material, it is present on a sector with a 
great perspective of growth in the future, the main reason being the increase of the old 
population.  
The Medcom Tech´s activity is developed through four lines of business. These are: 
trauma and biomaterial (traumatologic reconstructive products for upper and lower 
extremities, and bone substitutes); backbone (implants for the treatment of disorders of 
the spine); orthopaedics (knee and hip prostheses) and the treatment of vertebral 
fractures.  
 
2.2 MEDCOM TECH´S FEATURES  
 
One of the reasons for which analysing Medcom Tech turns out to be very interesting, 
is for the expectations of growth that it can bring in the present and in the future, 
because nowadays technology grows at an impressive speed.  
As technical advances have a great influence on the increase of life expectancy, and 
according to Juan Sagales, one of the managers of Medcom Tech, “we are lucky to 
find ourselves in a stable and anti-cyclical sector that does not take too much notice of 
the effect of the economic crisis”.   
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Another fact for the company is that according to the information of the National 
Institute of Statistics 31.9% of the people in the world will be over the age of 64 in 
2049.  
Even so, there have been important changes after the economic crisis, and the most 
important has been the commitment to develop its own technology, as well as the 
creation of two new companies, Medcom Flow and Medcom Advance, which have 
been financed through the alternative stock market (MAB). This fact has allowed them 
to triple their sales since their launching, achieving great company habits.  
 
Medcom Tech´s company is located in Barcelona. The registered office is Partenon 
Avenue. Medcom Tech is a global company with advanced and self-technology, in 




Figure 1 Medcom Tech´s geographical location 
Source: Google Maps  
 
Medcom Techs makes de difference from the rest of the pharmaceutical companies, 
because it focuses its activity on the commercialization of products, where the patents 






2.3 MEDCOM TECH´S HISTORY  
 
The beginnings of Medcom Tech go back to 2001 when Juan Sagales and Roca de 
Viñals set up the company in order to sell products in the areas of orthopaedic surgery, 
traumatology and neurosurgery.  
 
With the creation of Medcom Tech two fundamental aims were established in order to 
bring something new to the area of orthopaedic surgery, the first one being bringing the 
best available technology to the markets where the company operates, and the second 
one by doing it without intermediaries.   
 
Since Medcom Tech was set up, there have been many events that have had a crucial 
meaning in Medcom Tech history, for example its incorporation in MAB (Alternative 
Sotck Market) on march 25 of 2010. MAB is a market used for companies with small 
capitalization that want to grow with regulations adapted to their characteristics.  
 
Another significant event in Medcom Tech´s history was the one that took place on 
January 29th 2013, when the company Medcom Flow S.A was created, with the 
purpose of making and selling products for anaesthesia. This decision responds to 
Medcom Tech´s strategy of promoting the development of their first product, the video 
laryngeal mask. Later that year, on July 29th 2013 Medcom Advance S.A was set up in 
order to develop products based in nano-biotechnology. Having said this, it is 
understandable that Medcom Tech became a model in the biotechnology sector.    
 
2013 was a very important year for Medcom Tech, because a very important strategic 
refocus on the production of its own patents took place, in order to promote the 
investigation and development through Medom Flow and Medcom Advance.  
 
Medcom Flow is a division dedicated to create innovative products. It manufactures 
products technologically advanced with its own patents and sells them through 
Medcom Tech and other distributors in more than 60 countries.  
 
Medcom Advance is a scientific company that researches and develops patents using 
nanotechnology. As Juan Sagales said: “If we wanted to be big we had to have our 




2.4 MEDCOM TECH´S STRATEGY  
 
Medcom Tech, under the responsibility of Juan Sagales and his partners, has been 
able to understand the needs of the sector of distribution of orthopaedics products, 
trying to cut down  prices thanks to technology.    
 
 Being aware of the constant technological changes has been the key for Medcom 
Tech´s success in such a specialized sector. Since every few month new products 
appear to substitute the previous ones making them obsolete.  
 
Medcom Tech´s strategy has focused on being able to have access to the technical 
innovations and introducing them on the markets where it operates. It is also 
considered a priority to Medcom Tech to quickly detect and take technology to 
hospitals, because one of the disadvantages observed by Medcom Tech was the 
unreasonable amount of time spent from the production of the product until his arrival 
to hospitals. Another important aspect in Medcom Tech´s strategy is its evolution from 
being only a supplying company to carrying out its own projects.  
 
Medcom Tech´s president, Juan Sagales bets on innovation as the way of growth of 
the company. And he thinks it is essential to take advantage of this period of crisis that 
makes raw material cheaper. 
 
Crisis has also supposed crucial changes in Medcom Tech´s strategy, because the 
cuts in the sanitary area have been clear. And even more in the countries where they 
operate, which have been hit hard by the crisis. This has done Medcom Tech´s 
strategy cut down the weight that was given to the public sector, because it makes the 
payments very late. This has allowed them to reduce payment period. Today, the 
delays are 189 days, on average. They have been reduced from 275 days.  
 
Medcom Tech´s strategic plan is to continue growing on the market where it is already 
and also continue with the developing of his own products.  
 
Medcom Tech is present in a market with a huge growth potential, another feature is 
countercyclical present in this market. Because Medcom Tech´s main products have 
application in osteoporotic fractures which mostly happen in two moments of our life, 




The market in which Medcom Tech operates is considered to be an increasing market 
because according to the short-term population projection elaborated by de INE there 
is slowdown in the population growth rate in Spain. Life expectancy is expected to 
increase about two years for men and 1.6 for women.  
 
This means that people older than 64 years will represent approximately 20% of the 
population in Spain in 2019. All this leads to a major percentage of people with 
osteoporotic problems. Therefore, the demand for products distributed by Medcom 
Tech will increase, due to the ageing of the population. According to the International 
Osteoporosis Fundation it is estimated that in 2050 hip fracture will increase by 310% 
in men and 240% in women.  
 
   
Figure 2 Population pyramid in Spain (2009 and 2019)  
Source: Projection of the population of Spain in the short-term, 2009-2019 of the INE 
 
Medcom Tech has pointed its strategy to stand out from the rest, trying to provide 
added value to its customers. That is why it optimizes the distribution process of the 
products, being the only intermediary between the manufacturers and the clients, thus 
allowing a wider knowledge about the product and so they can advise not only their 







2.5 MEDCOM TECH´S PRODUCTS  
 
Medcom Tech structures its activities in four divisions or lines of business:   
 
1. Orthopaedic surgery and Biomaterials:  
 
Reconstructive products are marketed, from prosthesis and plaques for the 
lower and upper extremities (ankle, foot, shoulder, wrist, elbow and hand) to 
orthopaedic and fixation fracture products. They also have biomaterial that work 
like bone substitutes. These products constitute approximately 35% of Medcom 
Tech´s billing.  
 
 
Figure 3 Orthopaedic and biomaterial products (upper extremity)  
Source: Medcom Tech´s website  
 
 
Figure 4 Orthopaedic and biomaterial products (low extremity)  









2. Backbone:  
 
This division sells products for spinal, cervical and lumbar treatment. It 
constitutes about 43% of the total turnover.  
 
 
Figure 5 Backbone products  
Source: Medcom Tech´s website  
 
 
3. Orthopaedics:  
 
The orthopaedic division focuses on the commercialization of knee and hip 
reconstructive products. An important fact is that this division invoices less than 
the previous ones, having a turnover of around 15%.  
 
 
Figure 6 Orthopedic products  








4. Kyphoplasty:  
 
It is the division that sells the least with 9% of Medcom Tech´s total turnover, its 
activity deals with the commercialization of products for vertebral fractures with 
crushing.  
 
The reason why Medcom Tech diversifies its activity in four divisions is to minimize the 
dependence to someone of the divisions.  
 
Medcom Tech has a great variety of products for orthopaedic surgery, trauma and 
neurosurgery as well as anaesthesia. Medcom Tech has a wide range of quality 
products in each of these divisions.  
 
Over the years Medcom Tech has been introducing products of diverse manufacturers, 
such as the bone substitutes of Biocomposites Ltd. In 2005 it increased significantly its 
relevance when it obtained the distribution rights of the North American company Hand 
Innovations Inc, which resulted in a great number of innovative products in hand 
surgery being introduced in the Spanish market  
 
2.6 CUSTOMERS AND SUPPLIERS  
 
 CUSTOMER:  
 
Medcom Tech significantly widened his client´s portfolio during 2005 and 2006 when it 
moved from working with twelve clients to working with more than one hundred 
hospitals. And it will continue to add new clients, mainly clinics and hospitals in Madrid. 
To achieve this goal, Medcom Tech has increased the commercial team of Spain. 
Medcom Tech´s strategy has allowed itself to develop a loyal client´s portfolio. 










 SUPPLIERS:  
Medcom Tech ended 2009 with 14 suppliers and a portfolio of 50 innovative products 
with presence in more than 400 hospitals in the Iberian Peninsula.  
 
The main suppliers of the orthopaedic surgery: ASCENCION ORTHOPEDICS, INC; 
TRIMED, ICN; SMALL BONE INNOVATIONS, INC (SBI); BIOTECH INTERNAIONAL; 
APP IMPLANTATE AG; MEMONTAL TECHNOLOGIES. 
 
The main suppliers of biomaterials area: DOCTORES RESEARCH GROUP, INC 
(DRG); ORTHOGEM LTD.   
 
2.7 SECTOR IN WHICH IT OPERATES  
 
Medcom Tech is a strong Spanish company, with subsidiary companies in Italy, 
Portugal, Serbia and Dominican Republic. Medcom Tech provides more than 500 
hospitals. The company has a staff of 140 employees and has in mind keeping 
growing.  
 
2.8 MARKET STRENGHT  
 
Medcom Tech is mainly present in Catalonia and Galicia, with a great profitability, 
which is reflected in its point of balance, which from the second year already was 
overcoming the break-even point. The biotechnological company tries to continue 
growing through its own patents and with the opening of new markets.  
 
2.9 OPENING TO INTERNATIONAL MARKET 
 
According to Juan Sagales, CEO of Medcom Tech, the main aim is to increase its 
presence in other countries. Medcom Tech, headquartered in Viladecans (Barcelona), 
nowadays has 140 employees and its purpose is to grow in Spain and also in the 
United States.  
As shown in the beginning of the article, two of Medcom Tech´s social rules: “Medcom 
Tech S.A purpose is acting as counsellors, intermediaries, manufacturers and 




2.10 ORGANIZATIONAL STRUCTURE OF MEDCOM TECH S.A   
 
MEDCOM TECH´S ORGANIZATION CHART 
Medcom Tech´s structure is divided into the following departments: 
 
Figure 7 Organization chart of Medcom Tech S.A  
Source: Medcom Tech´s website  
 
As you can see on the structure reflected in the organization chart, it shows the 
Medcom Tech´s mission of a vertical integration in order to make the distribution 
process of the products easier, which involves further communication between the 







3. ECONOMIC AND FINANCIAL EVOLUTION OF THE COMPANY  
 
MEDCOM TECH´S FINANCIAL INFORMATION  
The financial information that will be referenced during the essay belongs to Medcom 
Tech´s annual accounts for the financial exercises of 2012, 2013, 2014 and 2015.  
Also, it is worth mentioning that the information provided is given in Euros.  
The annual accounts of the company from the exercise 2012 to 2015 are included as 
Annex I of this essay.  
Based on the fact that all the financial information that appears in the essay has been 
reviewed by the auditors of Medcom Techs, BDO Auditors S.L, who for the four years 
analysed have shown the judgement that they express in all the significant aspects a 
faithful image of the financial situation of the company, Medcom Tech S.A, as well as of 
the results and the cash flows. All this in accordance with the normative of the financial 
information that results from the accounting principles.   
The auditor´s reports from the annual accounts of the exercises 2012, 2013, 2014 and 
2015 are enclosed as Annex II.  
Before starting with the analysis, it is important to say that the annual accounts of the 
years selected are perfectly comparable, because they have been formulated 
according to the regulations of the General Accounting Plan approved by the Royal 
decree 1514/2007.  
Another relevant aspect regarding the annual accounts of Medcom Tech SA is that 
according to the limits and conditions that are presented in Royal Decree 1159/2017, of 
September 17, it is not obliged to present the consolidated accounts for what the 
analysis which I have carried out has been on the annual accounts for Medcom Tech 
Spain. 
The aim of the essay is the analysis of the financial statements that will allow me to 
have a well-founded opinion about the economic and financial situation of Medcom 
Tech S.A.  
For this I will structure the analysis in the following way:  
3.1 Patrimonial and financial analysis  
3.2 Analysis of the assets management  
3.3 Economic Analysis  
3.4 Analysis of profitability and self-financing  
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3.1 FINANCIAL AND PATRIMONIAL ANALYSIS  
 
Analysing the composition of the balance sheet allows to know the liquidity and the 
equity balance of the company. Medcom Tech´s balance sheet from the exercise 2012 
to 2015 is composed by the following liquid assets:  
 
Table 1 Balance sheet composition (2012-2015) 
 
 






To be able to study the relative importance of each equity mass, I have analysed the 
percentage that represents each item over the total assets or liabilities.  
 




Source: Source: Own preparation based on Medcom Tech´s annual accounts    
 




 High weight of the current assets over the total (72.39%), showing that it is a 
business of commercialization and services rather than a strong industrial 
manufacturing structure.  
 
 
 Current assets items evolution:  
 
 
Figure 8 Current assets evolution (2012-2015)  
Source: Own preparation based on Medcom Tech´s annual accounts    
 
Firstly, a correlation with the stock and cash items could be observed, since the 
increase of the stock throughout the years has influenced on Medcom Tech´s cash 
manage, decreasing cash and other liquid assets.  
 
Secondly, there is a gradual reduction in the commercial sundry debtors and other 
receivable accounts. This is because Medcom Tech has managed to reduce its 




This is also seen in relative terms, because in 2012 it represented almost 50% of 




 Non-current assets evolution  
 
 
Figure 9 Non-current assets evolution (2012-2015)  
Source: Own preparation based on Medcom Tech´s annual accounts    
 
The elements that compose the most part of the non-current assets are on the one 
hand the investments on group companies and associates, it is possible to see in 
the previous graph the increase over the years; on the other hand, the tangible 
assets that corresponds to the facilities.  
 
 Significant growth in the participation in other companies, as a result of the 
setting up of two companies (Medcom Flow and Medcom Advance) with the 
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 Important weight of the client´s item (32.15%) because Medcom Tech mainly 
works with public institutions (hospitals…), but with a tendency to decrease due to 





 Total assets evolution  
 
 
Figure 10 Graphical representation of the total assets evolution (2012-2015)  
Source: Own preparation based on Medcom Tech´s annual accounts    
 
The Medcom Tech´s assets show a clear increase during the years 2012 to 2015, 
in line with the growth that the company is experiencing.  
 
 Also, a high percentage of own funds (42.09%), providing with patrimonial 
solvency to the company, although its relative weight has decreased in the last 

















 Growth of the bank long-term debt in 2014, in line with the increase of 
investments in the group companies, but it highlights that the increase of the year 








Apparently, part of this increase of bank short-term debt has also financed the 





 Medcom Tech has a positive hedge fund (working capital) which apparently 




But if we consider only the realizable and the available assets (debtors and cash) 
for the analysis of the liquidity, it means a lower amount than the short-term 
liabilities, which could lead to liquidity tensions. This fact confirms that the irregular 
financing of fixed assets with short-term resources can end up by creating treasury 







 Net and Liabilities evolution  
 
 
Figure 11 Graphical representation of net worth and liabilities evolution (2012-2015)  
Source: Own preparation based on Medcom Tech´s annual accounts   
 
Net equity increased slightly during 2012, and has remained constant since then, 
this may be due to its positive results during those years, as will be seen below in 
the statement of expenses and income. Non-current or long-term liabilities first 
show a slight decline and subsequently change a more constant trend. On the 
other hand, the liabilities in the short term follow an upward trend with a notable 





















2012 2013 2014 2015
Total Patrimonio Neto y Pasivo 
 PATRIMONIO NETO  PASIVO NO CORRIENTE          PASIVO CORRIENTE
26 
 
3.2 ASSET MANAGEMENT ANALYSIS  
 
 The average storage period is high (460 days) with the consequent need to finance 
the growth of the business and therefore the stock needs, either via suppliers or 




 The growth of the term of payment to suppliers (231 days) corroborates the 




This increase in the payment term may be a consequence, either of a good 
management of the term of payment to suppliers, or because some payment has 
had to be extended by tensions of treasury.  
 
 At the same time, promoting the sales to the private sector, in exchange for public 
health care, has allowed the company to reduce its credit terms for billing from 203 





 The consequence of these terms is a financial period of ripeness of more than one 
year (373 days), which forces an excessive effort for its financing, hence the 
change of strategy towards the private client, which has allowed to reduce the term 




Summing up, I can say that there are generally very long terms, as a consequence of 
the typology of the customers and the market in which it operates, not meaning in any 




3.3 ECONOMIC ANALYSIS  
 
Before beginning with the income statement (statement of earnings) analysis, it should 
be remember that Medcom Tech is not obliged to present the consolidated annual 
accounts, which makes a complete analysis of the group more difficult. For this reason, 
all the information that is shown later corresponds to Medcom Tech Spain annual 
individual accounts.  
 
Table 3 Profit and loss report (Expenses and revenues statement) (2012-2015) 
 












Table 4 Percentages representing each item over total net turnover (2012-2015) 
 
Source: Own preparation based on Medcom Tech´s annual accounts    
 
 An important upward trend of the turnover (net sales) can be observed from 
16MM in 2012 to 23MM in 2015, with annual double-digit percentage growth. A sign 




 The gross margin is about 60%, generating an added value that allows to cover 





 One of the most important items is the Personnel Expenses, which represents 
27% of sales, with increases higher than the increase in business in the last years. 
This structure increase might allow it to continue growing without new extensions, 




 Financial expenses represent 4% of sales, rather high as a consequence of the 
financing that it must endure due to the high storage period, and for the financing 





 Exchange rate differences item stands out for its high amount in certain years. 
As a result of the strong appreciation of the dollar against the euro, because a great 




 Earnings before taxes (Income before taxes) reflects the following evolution and 





They are results with good percentages on net sales (net revenue), although 
Medcom Tech have suffered a decrease for the last two years, it has been due to 
punctual facts that do not have to have continuity in time; as they have been the 





 Evolution of the Profit and Loss Account  
 
 
Figure 12 Evolution of the main items in the profit and loss account (2012-2015) 
     Source: Own preparation based on Medcom Tech´s annual accounts    
 
It might be said that nowadays Medcom Tech has a good operating result what 
turns out to be positive and shows the maturity that has the company in the sector in 
which operates, because it is already a company established in its market and it has 
a good stability.  
 
In my opinion, the company has a balanced structure of the profit and loss report, 
with an adequate gross margin and good results, with the only drawback of 
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3.4 COST-BENEFIT AND SELF-FUNDED ANALYSIS  
 
I am going to continue the financial statements analysis with the help of some ratios, in 
order to widen my knowledge about Medcom Tech, and so the conclusions will be 
coherent with the patrimonial and economic analysis carried out so far from absolute 
and relative figures.  
 





Clearly the business development generates important resources, with the positive 
fact that they are also stable over the time.  
 




Theoretically it should not have problems to cover its payment commitments, but 
when we adjust the ratio, without taking into account the stocks, it changes to be 
below the unit; which can generate treasury tensions that should be covered with 
alternative financing from suppliers or banks.   
 
This conclusion together with the one carried out in the assets and liabilities 
financial analysis, in which I was mentioning the irregular financing of long-
term investments (share and fixed assets) with short resources (banks), is 
showing us clearly the possible tensions of treasury it may have for having 







 Return on assets (ROA), which will allow me to analyse if the profitability obtained 
from the economic resources is appropriate, and if it is enough in order to know if a 




Even though the ratio is positive, it may be tight and restricting of a leverage effect,  
Keeping in mind the current loan cost offered by banks. 
 
Moreover, if I break it down in the components that form it (margin x rotation), I 
notice how the limiting effect acting negatively over the margin obtained is rotation. 
This again helps corroborate the conclusion reached in the asset management 
analysis where I mentioned very long terms of storage and charging clients.  
 
This is clearly seen in the following graphs:  
 
 
Figure 13 Margin (ROA component)  
Source: Own preparation based on Medcom Tech´s annual accounts    
 



















Figure 14 Rotation (ROA component) 




Figure 15 Assets profitability graphical representation (ROA)  
Source: Own preparation based on Medcom Tech´s annual accounts    
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 Operative risk. This ratio is going to help me study the safety margin that the 





In this case, it is showing me that sales might decrease up to 16,6 % without the 
company entering into losses. 
 
Everything that is approaching to an operative risk of 1 it is to minimize the risk to 
facing declines in the market demand. In this case, I can see that the tendency is to 
go up, consequence of the increase of the business, which has forced to extend 
fixed structure (especially personnel), which means that the break-point rises, 
generating more risk facing variations of the sales.  
 
 Indebtedness. This ratio determines the degree of the indebtedness of the 
company in relation to the own funds. Although this ratio by itself cannot give us 
many conclusions, it can indicate the weight of the distribution of the debt between 




It can be observed an important increase of the indebtedness in the last years, 
especially in the short term. This can lead to liquidity tensions in the short term.  
 
This ratio should be completed with another ratio, CashFlow/Debt long term, which 
indicates the capacity to repay the debt in the long term. As we observe in the 
following table, it could be amortized approximately in two years, with the current 






Nevertheless, as I have repeatedly mentioned along the essay, the only problem 
that could present Medcom Tech will always come from the unorthodox financing of 
the non-current assets with the current liabilities (bank debt); for this reason, this 
last ratio can lead us to a misunderstanding.  
 
 Return on equity (ROE). The purpose of any company is to reward the capital 
over the profitability of an investment without risk. In the case of Medcom Tech it is 
3,84%, which initially would not be ideal, but keeping in mind that it is a company in 
growth and with strategic changes, it may be giving up this initial profitability in 




Dividing this profitability into more detailed ratios, we can see where the reason for 




Finally, as might be expected, because I have already mentioned it several times in 
the essay, the main problem is in the limited turnover of the assets, in addition to 
the little contribution of the leverage to the financial profitability, although this 




Figure 16 Return on equity graphical representation (ROE)  
Source: Own preparation based on Medcom Tech´s annual accounts   
 
Medcom Tech during the years under review has suffered a slight decrease. 
 
 Comparison between Return on assets and Return on equity 
 
 
Figure 17 Comparison between Return on assets and Return on equity 
Source: Own preparation based on Medcom Tech´s annual accounts    
 
As it can be seen in the previous graph of lines, the difference between Return on 
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 Z-score  
 
The Altam Z-Score is a simple method of analysis of the financial strength of a 
company. This method tells us about the probabilities of bankruptcy established by 
a combination of financial ratios. The Altam Z-Score model was created in 1960 by 
Edward Altman, teacher of the University of New York.  
 
I am going to use it as a complementary and illustrative ratio from the nearness to a 




These values indicate a deterioration trend over the years, and although according 
to this predictive model, it may be close to a situation of risk, this information has to 
be considered within the context of market, client, product, strategy and growth of 
Medcom Tech´s business.  
 
Taking it as simple complementary information, which only shows the weaknesses 
already commented that the company has a financing of the fixed assets with 
current liabilities and a very limited rotation of assets.  
 
Note: 
The Altman Z-Score model is interpreted of the following way: 
Z-Score beyond 3: The company does not present probability of bankruptcy and it 
is considered safe.  
Z-SCORE between 2.7 and 2.9: It is in precaution zone. A very detailed analysis 
should be done before joining the company.  
Z-SCORE between 1.8 and 2.7: It is in alert zone. If the financial conditions do not 
change quickly, it is very probable that the company will go bankrupt in the next 
two years.   




4. DISCUSSION AND CONCLUSION  
After analysing Medcom Tech´s financial statements, I can enumerate the following 
conclusions to which I have arrived.  
- Medcom Tech´s is a highly commercial company due to the great weight of the 
current assets in its balance sheet (72.39%)  
 
- Its own funds represent 42.09% of the liabilities, proving a great equity balance, 
but with the exception of having a downward trend for the last 4 years, as a 
consequence of having financed the setting up of two new companies, Medcom 
Flow and Medcom Advance.  
 
- An important growth of the non-current asset (mainly by the investments 
mentioned before) increasing greatly its relative weight in the balance sheet 
from 14.48% in 2012 to 24.61% in 2015.  
 
- The previous investments have been financed in 2014 and 2015 with bank 
indebtedness. According to the balance sheets, in 2014 it was financed in the 
long term, but in 2015 it used short-term bank financing, even for financing part 
of the increase of the tangible fixed assets, also with short resources; a 
measure that does not seem very orthodox and may lead to suffer occasional 
treasury tensions.    
 
- Its working capital is positive, but if we adjust it eliminating the stocks, it can be 
observed that it changes to be lower than the current liabilities, confirming the 
previous conclusions of being able to suffer punctual liquidity tensions for 
having financed non-current assets with current liabilities.  
 
- It is thus important to focus on the trend when assessing growth development, 
therefore, there is an important trend of growth of the net sales from 16MM in 
2012 to 23MM in 2015, with annual double-digit percentage growth. Very 
important information to point out.  
 





- Important weight of personal expenses (27% on sales), this is normal because 
Medcom Tech is a commercial company that must have an important sales 
force, with importance to its work of I+D (Research and Development), and 
which is also in continuous growth, so it is logical that it is extending its 
structure.  
 
- The financial expenses represent 4% of sales, too high considering the fact that 
the scenario of interest rates in the last years has decreased. These expenses 
are being affected by the increase of financing.  
 
- With a positive Cash Flow, and above all stable over the time of about 7% on 
sales, it is enough to be able to be facing his long-term bank debt. With the 
exception already mentioned that maybe it may have to restructure his bank 
debt to shortly or renew it.  
 
- The analysis of its operational risk determines the safety margin that it has at 
the moment when the level of sales occasionally falls, the analysis indicates 
that Medcom Tech can endure a 16% decrease in sales without fall into losses.  
 
- Although this percentage has been decreasing in the last years, as a result of 
the increase of the staff (the expenses of personnel have increased), which in 
turn is a necessary consequence of the growth of the business; it is expected 
that the company could continue growing over a period of time without new 
structure extensions, which would reduce the operative risk.  
 
- As far as assets management is concerned, I have observed a very long period 
of storage and payment. The average storage period is 460 days and the 
payment period is 144 days. These periods lead to strong financing needs. This 
may also explain the reason why short-term bank debt has increased.  
 
- Although it is necessary to highlight the positive management that is taking 
place, because the payment terms have been reduced in the last years from 
203 to 164, and to 144 days in 2015. At the same time, the supplier period has 






The last figure may come either from a good management of deferral of 
payments, or from some renovation of payment to suppliers, which being the 
case, it would continue corroborating the predictable treasury tensions already 
mentioned.  
 
- The Average financial period to maturity of Medcom Tech is 373 days in 2015, 
and although it has been decreasing in the last years, it is very high, penalizing 
the assets profitability and consequently the own return on equity, which stands 
at 3.84%.  
 
- Finally, I used the Altam Z-Score indicator to analyse the health of the company 
and as a contrast of my conclusions. Its calculation gives me a value of 1.89 
who is in the alert zone, very close to the maximum financial danger. It seems 
to me that this figure corroborates the conclusions which I have made: a wrong 
financing of non-current assets with current liabilities, as well as the high 
storage periods and collection times, which is forcing to extend the payments to 
its suppliers and to obtain alternative financing for the long period of financial 
maturity. All this damages of the financial situation of the company, becomes 
visible with the calculation of the Altam Z-Score indicator.  
 
- Regarding the limitations of the essay, I can mainly say that although Medcom 
Tech is obliged to formulate the annual accounts by the article 235.1 of the 
Royal Decree 1/20120 of July 2, it is not to the presentation of the consolidated 
accounts of the group, which is a major limitation in its analysis. Because it is 
extremely important to know the financial health of the whole business, and not 
only of the parent company. Therefore, this financial economic analysis of 
Medcom Tech S.A could be extended through the analysis of the consolidated 
accounts of the Medcom Tech´s group.  
 
- In summary, and as a diagnosis, and despite the poor data of the Altman Z-
Score index, it is necessary to take into account the context in which the 
company operates: the product that it commercializes (advanced technology), 
the type of customers (public health care), and an attractive and growing market 
(the population pyramid widens in the objective age range of the company). 
That is why in my opinion the company will not find itself with more problems 
than adequate restructuring of its indebtedness A better liquidity position with 



















Books of analysis:  
- Análisis Económico Financiero, Oriol Amat                                                      
- Las claves del análisis económico-financiero de la empresa, Jose de Jaime 
Eslava  
- Análisis Económico-Financiero de la Empresa: Un análisis desde los datos 










6.1 ANNEX I: BALANCE SHEET & P&L ACCOUNT OF 2012, 2013, 2014 & 2015  


































6.2 ANNEX II: MEDCOM TECH´S AUDIT REPORTS OF 2012, 2013, 2014 & 2015  


































6.3 ANNEX III: INDICATORS ABOUT MEDCOM TECH (RATIOS) 
 
3.1 THE MAIN RATIOS CALCULATED OF THE ANNUAL ACCOUNTS OF 




3.2 AVERAGE VALUE OF THE ITEMS OF ASSETS, LIABILITIES, NET AND 







3.3 ALL THE RATIOS CALCULATED OF MEDCOM TECH S.A (THROUGH 
EXCEL) 
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